NCT04791293View on ClinicalTrials.gov

The Model for End-Stage Liver Disease Sodium (MELD-Na) Score in Non-cirrhotic Patients With Gastric Cancer

CompletedOBSERVATIONAL

Enrollment

159

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

August 5, 2022

Study Completion Date

August 5, 2022

Conditions

Gastric CancerComplication,PostoperativeComplications; Gastrointestinal, PostoperativeMorality

Interventions

OTHER

MELD-Na score

MELD-Na scores will be compared between the groups

Trial Locations (1)

34029

Istanbul Training and Research Hospital, Istanbul

All Listed Sponsors

lead

Istanbul Training and Research Hospital

OTHER_GOV

NCT04791293 - The Model for End-Stage Liver Disease Sodium (MELD-Na) Score in Non-cirrhotic Patients With Gastric Cancer | Biotech Hunter | Biotech Hunter